Total Payments
$5,031
2024 Payments
$1,510
Companies
20
Transactions
219
Medicare Patients
1,260
Medicare Billing
$112,308
Payment Breakdown by Category
Food & Beverage$4,966 (98.7%)
Education$64.95 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,966 | 218 | 98.7% |
| Education | $64.95 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $867.78 | 55 | $0 (2024) |
| Lilly USA, LLC | $791.27 | 42 | $0 (2024) |
| Dermavant Sciences, Inc. | $583.97 | 14 | $0 (2024) |
| PFIZER INC. | $427.85 | 15 | $0 (2024) |
| GENZYME CORPORATION | $402.27 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $363.40 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $276.73 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $185.16 | 7 | $0 (2024) |
| Incyte Corporation | $181.69 | 10 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $167.55 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 70 | Dermavant Sciences, Inc. ($352.98) |
| 2023 | $1,157 | 63 | ABBVIE INC. ($271.02) |
| 2022 | $1,915 | 59 | Lilly USA, LLC ($395.10) |
| 2021 | $448.63 | 27 | AbbVie Inc. ($140.00) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $132.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $134.42 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: DERMATOLOGY | ||||||
| 09/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Immunology | ||||||
| 09/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.62 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $10.17 | General |
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Dermatology | ||||||
| 08/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 350 | 560 | $109,937 | $32,435 |
| 2022 | 12 | 320 | 469 | $88,655 | $31,965 |
| 2021 | 9 | 276 | 397 | $72,825 | $24,816 |
| 2020 | 10 | 314 | 441 | $72,075 | $23,092 |
Total Patients
1,260
Total Services
1,867
Medicare Billing
$112,308
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 106 | $22,602 | $7,336 | 32.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 20 | 99 | $17,266 | $5,317 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 51 | $15,298 | $4,600 | 30.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 41 | 54 | $14,969 | $4,375 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $9,627 | $2,646 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 33 | 36 | $8,947 | $2,413 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,505 | $1,516 | 27.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 23 | 35 | $5,689 | $1,442 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 34 | $4,572 | $1,393 | 30.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,073 | $545.15 | 26.3% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 12 | $2,254 | $470.93 | 20.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 13 | 71 | $1,137 | $382.30 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 98 | $16,794 | $6,688 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 66 | $14,762 | $6,044 | 40.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 28 | 46 | $11,992 | $3,761 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,210 | $2,339 | 44.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 15 | 39 | $7,617 | $2,124 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $5,780 | $2,034 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 43 | $4,619 | $1,920 | 41.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 23 | 25 | $6,822 | $1,855 | 27.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 16 | 19 | $3,800 | $1,804 | 47.5% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 20 | 26 | $5,318 | $1,702 | 32.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 22 | 31 | $4,789 | $1,491 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 15 | 37 | $1,150 | $203.94 | 17.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 107 | $16,050 | $7,245 | 45.1% |
About Shira Ehrlich, PA
Shira Ehrlich, PA is a Physician Assistant healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1679129068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shira Ehrlich, PA has received a total of $5,031 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 219 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,966).
As a Medicare-enrolled provider, Ehrlich has provided services to 1,260 Medicare beneficiaries, totaling 1,867 services with total Medicare billing of $112,308. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Brooklyn, NY
- Active Since 08/13/2019
- Last Updated 08/13/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1679129068
Products in Payments
- SKYRIZI (Biological) $682.72
- TALTZ (Drug) $664.59
- VTAMA (Drug) $583.97
- DUPIXENT (Biological) $475.59
- EUCRISA (Drug) $427.85
- Sotyktu (Drug) $323.15
- TREMFYA (Drug) $267.06
- OPZELURA (Drug) $181.69
- Otezla (Drug) $151.23
- COSENTYX (Drug) $144.36
- ILUMYA (Biological) $144.24
- RINVOQ (Biological) $132.04
- OLUMIANT (Drug) $126.68
- CLODERM (Drug) $116.70
- COSENTYX (Biological) $100.09
- HUMIRA (Biological) $53.02
- Bimzelx (Biological) $50.18
- XTRAC (Device) $49.41
- Cimzia (Drug) $38.36
- REMICADE (Biological) $26.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Brooklyn
Kaitlyn Nelson, Pa-C, PA-C
Physician Assistant — Payments: $262,844
Physician Assistant $262,844
Steven Kong
Physician Assistant — Payments: $55,299
Physician Assistant $55,299
Mrs. Melissa Velez, Rpa-C, RPA-C
Physician Assistant — Payments: $53,018
Physician Assistant $53,018
Hong Chen
Physician Assistant — Payments: $47,002
Physician Assistant $47,002
Gregory Celestin, Pa, PA
Physician Assistant — Payments: $30,181
Physician Assistant $30,181
Lindsey Axt, Pa-C, PA-C
Physician Assistant — Payments: $26,935
Physician Assistant $26,935